⌘K

Home/Filings/4/0001415889-25-024447

4//SEC Filing

Nussbaum Ran 4

Accession 0001415889-25-024447

CIK 0001691082other

View on SEC.gov Company Profile

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 6:25 PM ET

Size

5.5 KB

Accession

0001415889-25-024447

Insider Transaction Report

Form 4

Period: 2025-09-10

LB PHARMACEUTICALS INCLBRX

Director

Transactions

Award
Stock Option (Right to Buy)
2025-09-10+22,449→ 22,449 total
Exercise: $15.00Exp: 2035-09-09→ Common Stock (22,449 underlying)

Footnotes (1)

[F1]The option award shall vest in three (3) equal annual installments on September 10, 2026, September 10, 2027 and September 10, 2028, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file

4
form4-09122025_100911.xmlPrimary

Issuer

LB PHARMACEUTICALS INC

CIK 0001691082

Entity typeother

Related Parties

1

filerCIK 0001609805

Filing Metadata

Form type: 4
Filed: Sep 11, 8:00 PM ET
Accepted: Sep 12, 6:25 PM ET
Size: 5.5 KB

View on SEC.gov